Bayer announced Friday it would discontinue sales of its Essure birth control implant by the end of the year, bowing to a lengthy campaign by health advocates and thousands of women to get the device ...

Federal health regulators plan to warn consumers more strongly about Essure, a contraceptive implant that has drawn thousands of complaints from women reporting chronic pain, bleeding and other health ...

WASHINGTON (AP) — Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression ...

(NEW YORK) — Bayer Pharmaceuticals announced that it will no longer sell the permanent birth control implant Essure starting at the end of this year. Essure has courted controversy since it hit the ...

A Food and Drug Administration analysis found a sharp increase in reports from women about bad reactions to the sterility device called Essure, including persistent pelvic and abdominal pain. Data ...

Last month, the FDA scheduled a September panel meeting to take a hard look at Bayer's controversial birth control device, Essure, after getting complaints of clinical trial fraud and serious side ...

Yesterday, the FDA announced that Essure, a popular sterilization implant, could have serious side effects and ordered Bayer to conduct new safety trials on the device. In addition, the FDA drafted a ...

Over the past two decades, Bayer’s Essure — a nonsurgical birth control device — seriously harmed thousands of women when pieces of the metal coils splintered, leaving shards within the women’s ...

The FDA first announced their intention to provide a safety update about Essure late yesterday evening. Today's much anticipated report comes on the heals of a private citizen petition that raised ...

Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...